David Matusz, MD
Orthopaedic Surgery of the Spine · New York, NYNPI 1134115694
Payments from drug & device makers
Across 118 payments — averaging $75.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intrinsic Therapeutics$3K
- 4web, Inc.$1K
- Biedermann Motech, Inc.$1K
- Johnson & Johnson$551
- DJO, LLC$432
- Orthofix Medical, Inc.$425
- plus $2K from 11 others
What the payments were for
- Consulting fees$3,50039%
- Travel & lodging$1,10112%
- Food & beverage$4,17847%
- Education$1311%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intrinsic Therapeutics | 11 | $3,022 |
| 4web, Inc. | 12 | $1,453 |
| Biedermann Motech, Inc. | 8 | $1,327 |
| Johnson & Johnson | 26 | $551 |
| DJO, LLC | 4 | $432 |
| Orthofix Medical, Inc. | 36 | $425 |
| Alphatec Spine, Inc | 2 | $353 |
| Suvon Surgical LLC | 3 | $312 |
| Globus Medical(2 entities) | 4 | $276 |
| Medtronic | 2 | $237 |
| Precision Spine, Inc. | 1 | $142 |
| Cerapedics Inc. | 2 | $131 |
| Zimmer Biomet | 1 | $73 |
| Zimvie Inc. | 1 | $73 |
| Amgen | 2 | $44 |
| Si-bone, Inc. | 2 | $38 |
| Misonix Inc | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,911 in reported general payments places this provider in the 40th percentile of 161 orthopaedic surgery of the spine providers in New York.
See all orthopaedic surgery of the spine providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 15 | $111 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in New York
- Frank CammisaNew York$6.2M
- Frank SchwabNew York$5.1M
- Han KimNew York$4M
- Todd AlbertNew York$3M
- Jeffrey SpivakNew York$1.3M
- Aaron BucklandNew York$1.2M
- Sheeraz QureshiNew York$929K
- Fabien BitanNew York$884K
- Jeffrey GoldsteinNew York$765K
- Oheneba Boachie-AdjeiNew York$313K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.